• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Geron Corporation (GERN)

    -NasdaqGS
    3.80 Down 0.06(1.55%) Jun 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.86
    Open:3.86
    Bid:3.72 x 300
    Ask:3.98 x 200
    1y Target Est:5.50
    Beta:1.92
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:3.80 - 3.90
    52wk Range:1.76 - 4.49
    Volume:949,255
    Avg Vol (3m):3,873,340
    Market Cap:600.73M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNDown 1.55%600.73M
    BMYDown 1.02%109.69B
    GSKUp 0.20%106.84B
    NVSDown 0.33%249.15B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):501.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.07
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-10.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback